INO
NASDAQ
US
Inovio Pharmaceuticals, Inc. - Common Stock
$1.13
▼ $-0.61
(-35.06%)
Vol 19.9M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$119.5M
ROE
-157.6%
Margin
-25107.3%
D/E
0.00
Beta
1.74
52W
$1–$3
Wall Street Consensus
10 analysts · Apr 20263
Strong Buy
4
Buy
3
Hold
0
Sell
0
Strong Sell
70.0%
Buy Rating
Price Chart
Similar Stocks
ANIX
Anixa Biosciences Inc
$102.7M
ATYR
aTyr Pharma Inc
$76.7M
FBIO
Fortress Biotech Inc
P/E 28.5
$113.6M
GANX
Gain Therapeutics Inc
$123.8M
SERA
Sera Prognostics Inc
$113.9M
COEP
Coeptis Therapeutics Holdings Inc
$76.1M
XGN
Exagen Inc
$137.8M
EXOZ
eXoZymes Inc
$91.4M
PMVP
PMV Pharmaceuticals Inc
$66.5M
Earnings
Beat rate: 75.0%
Next Report
May 11, 2026
EPS Estimate: $-0.35
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.35 | — | — |
| Dec 2025 | $-0.36 | $0.06 | +$0.42 |
| Sep 2025 | $-0.43 | $-0.87 | $-0.44 |
| Jun 2025 | $-0.62 | $-0.61 | +$0.01 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -157.6% | -158.2% | -158.2% | -158.2% | -157.6% | -157.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -25191.1% | -25191.1% | -25191.1% | -25107.3% | -25107.3% |
| Gross Margin | — | 58.9% | 58.9% | 58.9% | 58.9% | 58.9% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 1.66 | 1.66 | 1.66 | 1.66 | 1.66 | 0.79 |
Key Ratios
ROA (TTM)
-127.9%
P/S (TTM)
422.28
P/B
1.0
EPS (TTM)
$-2.63
CF/Share
$-0.62
Rev Growth 3Y
-50.3%
52W High
$2.98
52W Low
$1.30
$1.30
52-Week Range
$2.98
How does INO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
INO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
422.3
▲
3186%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.0
▼
61%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
INO profitability vs Biotechnology peers
ROE
-157.6%
▼
134%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-25107.3%
▼
8656%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
58.9%
▼
25%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-127.9%
▼
174%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
INO financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.8
▼
82%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.7
▲
79%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
INO fundamentals radar
INO
Peer median
Industry
INO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
INO vs peers: key metrics
Latest News
XCharge North America, JOJO Superfast EV Charging To Deploy New EV Charging …
Nasdaq · Apr 03
US government sues Illinois, alleging unlawful efforts to regulate prediction markets
The Guardian · Apr 03
"A Defining Moment": Nano Nuclear Submits Construction Permit For Kronos Reactor In …
ZeroHedge · Apr 02
Domino's Pizza Group Names Nicola Frampton CEO
Nasdaq · Mar 31
Casino Group FY Loss Widens
Nasdaq · Mar 31